323 related articles for article (PubMed ID: 31077307)
1. Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State.
Diab J; Hansen T; Goll R; Stenlund H; Ahnlund M; Jensen E; Moritz T; Florholmen J; Forsdahl G
Inflamm Bowel Dis; 2019 Oct; 25(11):1780-1787. PubMed ID: 31077307
[TBL] [Abstract][Full Text] [Related]
2. A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression.
Diab J; Al-Mahdi R; Gouveia-Figueira S; Hansen T; Jensen E; Goll R; Moritz T; Florholmen J; Forsdahl G
Inflamm Bowel Dis; 2019 Feb; 25(3):490-497. PubMed ID: 30476077
[TBL] [Abstract][Full Text] [Related]
3. Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers.
Nyström N; Prast-Nielsen S; Correia M; Globisch D; Engstrand L; Schuppe-Koistinen I; Halfvarson J
J Crohns Colitis; 2023 Apr; 17(3):418-432. PubMed ID: 36219554
[TBL] [Abstract][Full Text] [Related]
4. Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets.
Bjerrum JT; Wang Y; Zhang J; Riis LB; Nielsen OH; Seidelin JB
Int J Biol Sci; 2022; 18(5):1813-1828. PubMed ID: 35342362
[TBL] [Abstract][Full Text] [Related]
5. Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.
Masoodi M; Pearl DS; Eiden M; Shute JK; Brown JF; Calder PC; Trebble TM
PLoS One; 2013; 8(10):e76532. PubMed ID: 24204637
[TBL] [Abstract][Full Text] [Related]
6. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
7. Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis.
Günaltay S; Repsilber D; Helenius G; Nyhlin N; Bohr J; Hultgren O; Hultgren Hörnquist E
Inflamm Bowel Dis; 2017 Jun; 23(6):932-945. PubMed ID: 28498152
[TBL] [Abstract][Full Text] [Related]
8. Imbalanced mucosal microcirculation in the remission stage of ulcerative colitis using probe-based confocal laser endomicroscopy.
Tian Y; Zheng Y; Teng G; Li J; Wang H
BMC Gastroenterol; 2019 Jul; 19(1):114. PubMed ID: 31262270
[TBL] [Abstract][Full Text] [Related]
9. Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis.
Diab J; Hansen T; Goll R; Stenlund H; Jensen E; Moritz T; Florholmen J; Forsdahl G
Metabolites; 2019 Nov; 9(12):. PubMed ID: 31783598
[TBL] [Abstract][Full Text] [Related]
10. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.
Braun A; Treede I; Gotthardt D; Tietje A; Zahn A; Ruhwald R; Schoenfeld U; Welsch T; Kienle P; Erben G; Lehmann WD; Fuellekrug J; Stremmel W; Ehehalt R
Inflamm Bowel Dis; 2009 Nov; 15(11):1705-20. PubMed ID: 19504612
[TBL] [Abstract][Full Text] [Related]
11. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
Lennon G; Balfe Á; Bambury N; Lavelle A; Maguire A; Docherty NG; Coffey JC; Winter DC; Sheahan K; O'Connell PR
Colorectal Dis; 2014 May; 16(5):O161-9. PubMed ID: 24345279
[TBL] [Abstract][Full Text] [Related]
12. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.
van der Post S; Jabbar KS; Birchenough G; Arike L; Akhtar N; Sjovall H; Johansson MEV; Hansson GC
Gut; 2019 Dec; 68(12):2142-2151. PubMed ID: 30914450
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761
[TBL] [Abstract][Full Text] [Related]
14. Confocal laser endomicroscopy: a new gold standard for the assessment of mucosal healing in ulcerative colitis.
Macé V; Ahluwalia A; Coron E; Le Rhun M; Boureille A; Bossard C; Mosnier JF; Matysiak-Budnik T; Tarnawski AS
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():85-92. PubMed ID: 25827810
[TBL] [Abstract][Full Text] [Related]
15. Lipidomic Profiling in Inflammatory Bowel Disease: Comparison Between Ulcerative Colitis and Crohn's Disease.
Fan F; Mundra PA; Fang L; Galvin A; Moore XL; Weir JM; Wong G; White DA; Chin-Dusting J; Sparrow MP; Meikle PJ; Dart AM
Inflamm Bowel Dis; 2015 Jul; 21(7):1511-8. PubMed ID: 25895111
[TBL] [Abstract][Full Text] [Related]
16. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
Patel A; Panchal H; Dubinsky MC
Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
[TBL] [Abstract][Full Text] [Related]
17. Applicability of endoscopic indices in the determination of disease activity in patients with ulcerative colitis.
Kucharski M; Karczewski J; Mańkowska-Wierzbicka D; Karmelita-Katulska K; Grzymisławski M; Kaczmarek E; Iwanik K; Rzymski P; Swora-Cwynar E; Linke K; Dobrowolska A
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):722-30. PubMed ID: 26894632
[TBL] [Abstract][Full Text] [Related]
18. Polyamine metabolism in colonic mucosa from patients with ulcerative colitis.
Obayashi M; Matsui-Yuasa I; Matsumoto T; Kitano A; Kobayashi K; Otani S
Am J Gastroenterol; 1992 Jun; 87(6):736-40. PubMed ID: 1590311
[TBL] [Abstract][Full Text] [Related]
19. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
Li Y; Nuij VJ; Baars JE; Biermann K; Kuipers EJ; Peppelenbosch MP; de Haar C; Janneke van der Woude C
Inflamm Bowel Dis; 2013 Jan; 19(1):132-40. PubMed ID: 22535619
[TBL] [Abstract][Full Text] [Related]
20. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
